The Relationship Between Glycemic Control and Length of Treatment in Tuberculosis Patients with Diabetes Mellitus
Ika Dyah Kurniati, Prihatin Iman Nugroho, Jalu Panjongko, Raihan Diki Ramadhanela
Advances in biological sciences research/Advances in Biological Sciences Research · 2024-01
Abstract
Comorbidity between diabetic mellitus (DM) and tuberculosis (TB) can raise the incidence of the other.Uncontrolled diabetes mellitus (plasma HbA1C level > 7.0%) and five additional risk factors were discovered to have an impact on the failure of TB treatment.This study aims to identify the relationship between glycemic control and the length of treatment in patients with tuberculosis and diabetes mellitus.This type of research is analytical observational research with a cross-sectional design.This study used a total sampling, namely where all members of the population were sampled, a total of 31 TB patients with DM from December 2019 technique to August 2023 who met the inclusion criteria.The tools used in this research are medical record data and blood lab results (HbA1c).Bivariate analysis was carried out using the chi square test with significance α = 0.05.The result of this research showed that the majority of TB-DM patient was male as 17 samples (54.8%).Most of the sample aged were > 50 years old as many as 22 samples (71.0%), 26 samples had HbA1c levels 7%, and the majority TB treatment duration 6 months were 18 samples (58.06%).The results of the chi-square test show p-value = 0.083 p (>0.05), meaning that there is no significant relationship between glycemic control and the length of treatment for TB-DM patients.The conclusion is glycemic control and treatment duration for TB-DM patients do not significantly correlate.
MeSH terms
- Glycemic
- Medicine
- Diabetes mellitus
- Internal medicine
- Tuberculosis